$ Value
$1.4M
Shares
79,590
Price
$18
Filed
Jan 14
Insider
Name
LO FRANCIS
Title
Chief People Officer
CIK
0001780660
Roles
Transaction Details
Transaction Date
2026-01-12
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
315,978
Footnotes
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025. | The option is fully vested and exercisable. | The options vested with respect to 1/4 of such shares on March 4, 2023, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested. | The options vested with respect to 1/4 of such shares on March 4, 2024, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested. | The options vested with respect to 1/4 of such shares on March 4, 2025, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
Filing Info
LO FRANCIS's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-08 | ADPT | M | $9K |
| 2026-04-08 | ADPT | ▼ | $340K |
| 2026-04-08 | ADPT | M | $0 |
| 2026-03-05 | ADPT | ▼ | $575K |
| 2026-03-04 | ADPT | A | $0 |
| 2026-01-12 | ADPT | M | $286K |
| 2026-01-12 | ADPT | M | $94K |
| 2026-01-12 | ADPT | M | $178K |
| 2026-01-12 | ADPT | M | $57K |
| 2026-01-12 | ADPT | ▼ | $1.4M |
Other Insiders at ADPT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| GRIFFIN MICHELLE RENEE | — | $735K | 2026-03-04 |
| NEUPERT PETER M | — | — | 2026-03-04 |
| HERSHBERG ROBERT | — | — | 2026-03-04 |
|
ROBINS CHAD M
CEO and Chairman
|
— | $12.4M | 2026-04-08 |
|
LO FRANCIS
Chief People Officer
|
— | $915K | 2026-04-08 |
|
PISKEL KYLE
Chief Financial Officer
|
— | $40K | 2026-03-04 |
|
RUBINSTEIN JULIE
President and COO
|
— | $7.2M | 2026-04-21 |
|
ROBINS HARLAN S
Chief Scientific Officer
|
— | $1.3M | 2026-04-08 |
|
BENZENO SHARON
Chief Commercial Ofc Imm Med
|
— | — | 2026-03-04 |
|
BOBULSKY SUSAN
Chief Commercial Officer, MRD
|
— | — | 2026-03-04 |
| OWEN KATEY EINTERZ | — | — | 2026-03-04 |